Assetmark »

Immunome shares owned by Assetmark

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Assetmark

Quarter filed Position value Share count Share price at filing
2025-12-31 $66k 3.1k 21.48
2025-09-30 $39k 3.4k 11.71

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Microsoft Corporation (MSFT)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Meta Platforms Cl A (META)

View all positions for Assetmark

Top funds holding Immunome

T. Rowe Price Investment Management
FMR
BlackRock
Point72 Asset Management
Vanguard Group
Redmile Group
Enavate Sciences GP
PRIMECAP Management Company
Leucadia National Corporation
State Street Corporation
EcoR1 Capital
Geode Capital Management
Toronto-Dominion Bank
Readystate Asset Management
Sofinnova Ventures

View all funds holding Immunome